The sp at around 20 cents and more for a while now, with the options having inreased in value, too. The buy to sell side ratio also much more encouraging that 2-3 weeks ago. Interesting.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
